CDC published ACIP 2020-21 influenza vaccination recommendations
On Aug. 21, 2020, the CDC published Immunization Practices Advisory Committee (ACIP) 2020-21 influenza vaccination recommendations. Routine annual…
JAMA reported on effect of remdesivir vs standard care on clinical status in patients with moderate COVID-19
On Aug. 21, 2020, JAMA reported that hospitalized patients with moderate COVID-19 randomized to a 5-day course of…
Failure to ﾑflatten the curveﾒ may kill more people than we thought
On Aug. 21, 2020, research by the University of Minnesota and the University of Washington found that every…
CureVac and EC advanced discussions to supply up to 405 million doses of potential mRNA-based COVID-19 vaccine
On Aug. 20, 2020, CureVac and the European Commission (EC) concluded exploratory talks outlining an Advanced Purchase Agreement…
GT Biopharma updated development of TriKE(TM) therapeutic for treatment of COVID-19 infection
On Aug. 20, 2020, GT Biopharma and Cytovance announced a collaboration agreement whereby Cytovance will providing drug development…
Oragenics signed a process development and manufacturing agreement with Avid Bioservices for Coronavirus vaccine
On Aug. 20, 2020, Oragenics and Avid Bioservices announced a process development and drug substance manufacturing agreement. Avid…
Evidence suggested children could play a larger role in community spread of COVID-19
On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…
OpGen announced CE-IVD Mark and commercial launch in EU of molecular diagnostic with PULB for detection of COVID-19
On Aug. 20, 2020, OpGen announced that its subsidiary Curetis GmbH had obtained the CE mark certification in…
Pfizer and BioNTech shared positive early data on lead mRNA vaccine candidate BNT162b2 against COVID-19
On Aug. 20, 2020, Pfizer and BioNTech shared additional Phase 1 safety and immunogenicity data from their U.S….
JAMA reported on evaluation for SARS-CoV-2 in breast milk from infected women
On Aug. 19, 2020, JAMA reported that to date, SARS-CoV-2 has not been isolated from breast milk, and…
CDC data showed disproportionate COVID-19 impact in American Indian/Alaska Native populations
On Aug. 19, 2020, the CDC released a new study that specifically examines how COVID-19 is affecting American…
Accelerate Diagnostics announced FDA Emergency Use Authorization for COVID-19 antibody testing system
On Aug. 19, 2020, Accelerate Diagnostics and BioCheck announced that the FDA had issued an Emergency Use Authorization…
Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaﾮ SARS…
BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditions
On Aug. 19, 2018, BioNexus KC announced it had been awarded a $42,900 grant from the Health Forward…
Bio-Techne and Leica Biosystems are acceleratied disease research with RNAscopeﾙ COVID-19 probes and the BOND RX
On Aug. 19, 2020, Bio-Techne in partnership with Leica Biosystems, announced the automation of RNAscopeﾙ COVID-19 probes on…
Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billion
On Aug. 19, 2020, Johnson & Johnson announced an agreement to acquire Momenta Pharmaceuticals, a company that discovers…
HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response
On Aug. 18, 2020, researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of…
Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19
On Aug. 18, 2020, Regeneron and Roche announced that they had joined forces in the fight against COVID-19…
NIH delivered $43 million to support convalescent plasma clinical trial
On Aug. 18, 2020, the National Institutes of Health awarded Albert Einstein College of Medicine and Montefiore a…
Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia
On Aug. 18, 2020, Vanda Pharma reported that interim analysis showed tradipitant may accelerate clinical improvement in SARS-CoV-2…
FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing
On Aug. 15, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
Quick and affordable saliva-based COVID-19 test developed by Yale scientists received FDA Emergency Use Authorization
On Aug. 15, 2020, a saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public…
AstraZeneca concluded agreement with the EC for supply of up to 400 million doses of AZD1222 COVID-19 vaccine
On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…
Mapping tool highlights NIH-funded small business successes
On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…
Philips launched Rapid Equipment Deployment Kit to COVID-19 response
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studies
On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…
HHS announced collaboration with Aegis Sciences for high quality rapid COVID-19 RT-PCR testing
On Aug. 13, 2020, the U.S. Department of Health and Human Services (HHS) announced combined investments of $6.5…
Baxter obtained FDA Emergency Use Authorizations for HF20 set and ST set used in CRRT during Covid-19 pandemic
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
FDA approved targeted treatment for rare Duchenne Muscular Dystrophy mutation
On Aug. 12, 2020, the FDA granted accelerated approval to NS Pharma’s Viltepso (viltolarsen) injection for the treatment…